These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 14568253)

  • 1. Intrapulmonary vascular dilatation and nitric oxide in hypoxemic rats with chronic bile duct ligation.
    Zhang XJ; Katsuta Y; Akimoto T; Ohsuga M; Aramaki T; Takano T
    J Hepatol; 2003 Nov; 39(5):724-30. PubMed ID: 14568253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arterial hypoxemia and intrapulmonary vasodilatation in rat models of portal hypertension.
    Katsuta Y; Zhang XJ; Ohsuga M; Akimoto T; Komeichi H; Shimizu S; Kato Y; Miyamoto A; Satomura K; Takano T
    J Gastroenterol; 2005 Aug; 40(8):811-9. PubMed ID: 16143886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of endothelial nitric oxide synthase in the pathogenesis of a rat model of hepatopulmonary syndrome.
    Fallon MB; Abrams GA; Luo B; Hou Z; Dai J; Ku DD
    Gastroenterology; 1997 Aug; 113(2):606-14. PubMed ID: 9247483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common bile duct ligation in the rat: a model of intrapulmonary vasodilatation and hepatopulmonary syndrome.
    Fallon MB; Abrams GA; McGrath JW; Hou Z; Luo B
    Am J Physiol; 1997 Apr; 272(4 Pt 1):G779-84. PubMed ID: 9142908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biliary cyst fluid from common bile duct-ligated rats stimulates endothelial nitric oxide synthase in pulmonary artery endothelial cells: a potential role in hepatopulmonary syndrome.
    Liu L; Zhang M; Luo B; Abrams GA; Fallon MB
    Hepatology; 2001 Mar; 33(3):722-7. PubMed ID: 11230754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caspase-3 inhibition prevents the development of hepatopulmonary syndrome in common bile duct ligation rats by alleviating pulmonary injury.
    Chen B; Ning JL; Gu JT; Cui J; Yang Y; Wang Z; Zeng J; Yi B; Lu KZ
    Liver Int; 2015 Apr; 35(4):1373-82. PubMed ID: 25113058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vildagliptin ameliorates intrapulmonary vasodilatation and angiogenesis in chronic common bile duct ligation-induced hepatopulmonary syndrome in rat.
    Mangoura SA; Ahmed MA; Hamad N; Zaka AZ; Khalaf KA; Mahdy MA
    Clin Res Hepatol Gastroenterol; 2024 Aug; 48(7):102408. PubMed ID: 38925324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of nitric oxide synthase in hyperdynamic circulation of rats with early or late cirrhosis secondary to common bile duct ligation.
    Kato Y; Katsuta Y; Zhang XJ; Ohsuga M; Akimoto T; Miyamoto A; Komeichi H; Shimizu S; Mizuno K
    J Nippon Med Sch; 2011; 78(3):146-55. PubMed ID: 21720088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased pulmonary vascular endothelin B receptor expression and responsiveness to endothelin-1 in cirrhotic and portal hypertensive rats: a potential mechanism in experimental hepatopulmonary syndrome.
    Luo B; Liu L; Tang L; Zhang J; Stockard CR; Grizzle WE; Fallon MB
    J Hepatol; 2003 May; 38(5):556-63. PubMed ID: 12713865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of liver damage on blood-borne variables and pulmonary hemodynamic responses to hypoxia and hyperoxia in anesthetized rats.
    Sepehrinezhad A; Dehghanian A; Rafati A; Ketabchi F
    BMC Cardiovasc Disord; 2020 Jan; 20(1):13. PubMed ID: 31931715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatopulmonary syndrome induced by common bile duct ligation in a rabbit model: correlation between pulmonary vascular dilatation on thin-section CT and angiography and serum nitrite concentration or endothelial nitric oxide synthase (eNOS)1 expression.
    Lee KN; Yoon SK; Lee JW; Kim KN; Park BH; Kwak JY; Jeong JS; Kim YH
    Korean J Radiol; 2004; 5(3):149-56. PubMed ID: 15467411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of heme oxygenase-1 by nitric oxide during hepatopulmonary syndrome.
    Carter EP; Hartsfield CL; Miyazono M; Jakkula M; Morris KG; McMurtry IF
    Am J Physiol Lung Cell Mol Physiol; 2002 Aug; 283(2):L346-53. PubMed ID: 12114196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. M2 macrophage accumulation contributes to pulmonary fibrosis, vascular dilatation, and hypoxemia in rat hepatopulmonary syndrome.
    Chen B; Yang Y; Yang C; Duan J; Chen L; Lu K; Yi B; Chen Y; Xu D; Huang H
    J Cell Physiol; 2021 Nov; 236(11):7682-7697. PubMed ID: 34041750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of receptor tyrosine kinase activation in cholangiocytes and pulmonary vascular endothelium in experimental hepatopulmonary syndrome.
    Yang W; Zhang J; Hu B; Wu W; Venter J; Alpini G; Fallon MB
    Am J Physiol Gastrointest Liver Physiol; 2014 Jan; 306(1):G72-80. PubMed ID: 24200956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tea polyphenols and Levofloxacin alleviate the lung injury of hepatopulmonary syndrome in common bile duct ligation rats through Endotoxin -TNF signaling.
    Zhu J; Qiu J; Chen K; Wang W; Zheng S
    Biomed Pharmacother; 2021 May; 137():111263. PubMed ID: 33516071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of pulmonary heme oxygenase-1 and nitric oxide synthase alterations in experimental hepatopulmonary syndrome.
    Zhang J; Ling Y; Luo B; Tang L; Ryter SW; Stockard CR; Grizzle WE; Fallon MB
    Gastroenterology; 2003 Nov; 125(5):1441-51. PubMed ID: 14598260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatopulmonary syndrome is associated with low sphingosine-1-phosphate levels and can be ameliorated by the functional agonist fingolimod.
    Baweja S; Kumari A; Negi P; Tomar A; Tripathi DM; Mourya AK; Rastogi A; Subudhi PD; Thangariyal S; Kumar G; Kumar J; Reddy GS; Sood AK; Vashistha C; Sarohi V; Bihari C; Maiwall R; Sarin SK
    J Hepatol; 2023 Jul; 79(1):167-180. PubMed ID: 36996943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary angiogenesis in a rat model of hepatopulmonary syndrome.
    Zhang J; Luo B; Tang L; Wang Y; Stockard CR; Kadish I; Van Groen T; Grizzle WE; Ponnazhagan S; Fallon MB
    Gastroenterology; 2009 Mar; 136(3):1070-80. PubMed ID: 19109954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TNF-α neutralization improves experimental hepatopulmonary syndrome in rats.
    Liu L; Liu N; Zhao Z; Liu J; Feng Y; Jiang H; Han D
    Liver Int; 2012 Jul; 32(6):1018-26. PubMed ID: 22672643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sorafenib treatment improves hepatopulmonary syndrome in rats with biliary cirrhosis.
    Chang CC; Chuang CL; Lee FY; Wang SS; Lin HC; Huang HC; Teng TH; Hsu SJ; Hsieh HG; Lee SD
    Clin Sci (Lond); 2013 Apr; 124(7):457-66. PubMed ID: 23043394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.